SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Nationwide listing for Cananray CBD secured in Morrisons

    By

    Cannaray CBD has announced its products will now be available to buy in Morrisons stores and on the retailers’ website.

    Products available include the Cannaray CBD Day and Night Oil Drops and its citrus-flavoured CBD Gummies. 

    Managing director of Cannaray CBD, Tim Clarke, commented: “We are delighted to be partnering with Morrisons to introduce Cannaray CBD to their shoppers. 

    Read more: Amazon’s CBD pilot sees further listings

    “As CBD usage is rapidly growing across the UK, we are proud to be helping millions of Morrisons shoppers to take their first step into trying high quality CBD as part of their regular wellness routine.”

    Cannaray CBD was founded with the aim of increasing access to CBD through its range of products formulated to be effective and enjoyable to use, all of which are independently lab tested for purity.

    Cannaray is fronted by brand ambassador, Claudia Winkleman, who began using Cannaray products two years ago to manage overall work and life pressures. 

    The CBD brand was the to invest in major brand advertising in the UK, with a national television and outdoor campaign featuring Claudia encouraging people to ‘Join the CBD Revolution’.

    Healthcare buying manager at Morrisons, Jacqueline Claughton, commented: “Being able to help our customers prioritise their health and wellbeing has been a huge focus for us this year. 

    “We have seen growing customer demand for CBD wellness supplements to be available in Morrisons stores and online, so we are delighted to be introducing Cannaray’s high quality and affordable CBD range to our shoppers.”

    [activecampaign form=31]

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free